MedTrace Logo

Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function

NCT01822860 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2015-03-25

No results posted yet for this study

Summary

Chlorthalidone will result in improved endothelial function compared to hydrochlorothiazide as measured by flow mediated vasodilatation.

Conditions

Interventions

DRUG

Chlorthalidone 12.5 mg

DRUG

Hydrochlorothiazide 25 mg

DRUG

Placebo

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Ahmed Aboeata, MBBCh · Creighton University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01822860 on ClinicalTrials.gov